troleandomycin has been researched along with danazol in 4 studies
| Studies (troleandomycin) | Trials (troleandomycin) | Recent Studies (post-2010) (troleandomycin) | Studies (danazol) | Trials (danazol) | Recent Studies (post-2010) (danazol) |
|---|---|---|---|---|---|
| 569 | 26 | 23 | 2,402 | 288 | 279 |
| Protein | Taxonomy | troleandomycin (IC50) | danazol (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Glucocorticoid receptor | Homo sapiens (human) | 4.314 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.019 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 4.314 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 5.698 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.3 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.012 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 4.314 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 4.314 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 5.698 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 4.314 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 8.85 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 0.0317 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 6.842 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
4 other study(ies) available for troleandomycin and danazol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |